Mevion Medical Systems, Inc. (formerly Still River Systems, Inc.) is a radiation therapy company dedicated to advancing the treatment of cancer. As the pioneering developer of modern proton therapy systems, Mevion provides innovative, safe, and effective solutions by transforming advances in medical technology and science into practical clinical reality.
Mevion’s flagship product, the MEVION S250 Proton Therapy System, is designed to preserve all of the treatment benefits of traditional proton therapy systems while removing the obstacles of size, cost, and complexity. Realizing this vision, Mevion has forever changed the economics and accessibility of proton therapy worldwide.
Founded in 2004, Mevion is a privately held company headquartered in the Boston metropolitan area with international offices in the United Kingdom and Japan.
Current Team (11)Update
Vice President Operations
Vice President of Advanced Development
SVP of Sales and Marketing
Vice President of Regulatory and Quality Assurance
Founder and CTO
Vice President of Engineering
CEO & Board Member
Funding Rounds (3) - $125MUpdate
Board Members and Advisors (7)Update
Caxton Advantage Life Science Fund is a New York-based financial firm that invests into companies...
Venture capital Firm
Venrock is a venture capital firm investing in technology and healthcare companies.
300 Foster St.
Littleton, MA 01460